Biotech InterMune Inc. (NASDAQ:ITMN) hit a three-year high on the stock market today after UBS lifted its price target for the company on bullish expectations for a drug launch. InterMune Inc. (NASDAQ:ITMN) stock opened today at $44.12 and is currently trading at $43.43. The stock showed a positive weekly performance of 7.39%.
Edison Investment Research today published a report on CytRx Corporation (NASDAQ:CYTR) entitled “Detailed Results On Aldoxorubicin Presented”. CytRx Corporation (NASDAQ:CYTR) stock opened at $5.35, in current trading session and currently is at $5.09, by losing -4.14%. The 52 week range of $1.95 – $8.35. Company’s market capitalization is 283.90 million.
Spherix Inc. (NASDAQ:SPEX) has started a patent litigation case against Verizon alleging that the company infringed four of its patents. The patents forming the basis of the case were developed by Nortel Networks. Spherix Inc. (NASDAQ:SPEX) stock is currently trading at $1.85. The EPS of the stock is -12.60. Company’s market capitalization is 22.70 million.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced today that the company is scheduled to present a corporate overview at the 2014 Wells Fargo Securities Healthcare Conference on Wednesday, June 18, 2014, at 2:25 p.m. Eastern Time (11:25 a.m. Pacific Time), at the InterContinental Hotel in Boston, Massachusetts. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock opened the session at $6.40, and now is at $6.42. The 52 week range of the Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock remained $4.05 – $8.48 and the day range was $6.32 – $6.43.
RBC Capital began coverage on shares of MannKind Corporation (NASDAQ:MNKD) in a research note issued to investors on Thursday, TheFlyOnTheWall.com reports. The firm issued an outperform rating and a $16.00 price target on the stock. MannKind Corporation (NASDAQ:MNKD) stock opened today at $10.00 and is currently trading at $10.04. The stock showed a negative weekly performance of -2.59%.
Leave a Reply